H.R. 6710 · 117th Congress
To direct the Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, to submit to Congress a report on barriers, including regulatory inefficiencies, to domestic manufacturing of active pharmaceutical ingredients, finished drug products, and devices, and for other purposes.
- Stage
- In committee
- Sponsor
- Yvette Herrell
- Introduced
- 2022-02-11
- Latest action
- 2022-02-14 · Referred to the Subcommittee on Health.
Subjects
Congressional oversight
Health
Infectious and parasitic diseases
Emergency medical services and trauma care
Trade restrictions
Drug safety, medical device, and laboratory regulation
Manufacturing